
Novo Nordisk A/S
NVO • Drug Manufacturers - General
$39.16
▲ +0.73 (+1.91%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$173.68B
Growth
11.7%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 33.1%Positive revenue growth · 22.7%Positive free cash flow · 6.52Consistent free cash flow · 5/5Reasonable earnings multiple · 14.05
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:49 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$39.16
Change1.91%
Shares Out4.44B
Market Cap$173.68B
52W Range35.12 - 64.16
Beta0.35
P/E4.53
P/S9.08
P/B4.33
P/FCF73.01
EV/Sales12.20
EV/EBITDA17.07
Price$39.16
Change1.91%
Shares Out4.44B
Market Cap$173.68B
52W Range35.12 - 64.16
Beta0.35
P/E4.53
P/S9.08
P/B4.33
P/FCF73.01
EV/Sales12.20
EV/EBITDA17.07
EV/FCF98.05
Earnings Yield22.09%
FCF Yield1.37%
Dividend Yield4.02%
Gross Margin80.98%
Oper. Margin41.30%
Profit Margin33.14%
Debt/Eq0.67
Current Ratio0.80
Quick Ratio0.57
Revenue 5Y11.71%
Target$42.33
Target Upside8.11%
Target Median$40.00
Target Range40.00 - 47.00
Volume1.87M
Avg Volume14.90M
EPS Surprise0.17
Investment DNA
How strong this company looks for long-term investors
71
out of 100
Business Quality
Margins, moat, returns
85/100
Financial Strength
Debt, cash, stability
53/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Stable or improving margins · 33.1%Positive revenue growth · 22.7%Positive free cash flow · 6.52Consistent free cash flow · 5/5Reasonable earnings multiple · 14.05Manageable debt level · 0.67
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 39 analyst votes · 2026-10-20
76/100
Bullish
Bullish
23
Hold
13
Bearish
3
Price Target
2026-08-07
Low
$47.00
Mean
$47.00
Median
$47.00
High
$47.00
🧾
No insider activity
No recent insider transactions available.
